The DOI matches its Crossref record; 106 of the 108 references it cites were found in a registry or an index.
Nanoparticle therapeutics: an emerging treatment modality for cancer
Abstract
Nanoparticles--particles in the size range 1-100 nm--are emerging as a class of therapeutics for cancer. Early clinical results suggest that nanoparticle therapeutics can show enhanced efficacy, while simultaneously reducing side effects, owing to properties such as more targeted localization in tumours and active cellular uptake. Here, we highlight the features of nanoparticle therapeutics that distinguish them from previous anticancer therapies, and describe how these features provide the potential for therapeutic effects that are not achievable with other modalities. While large numbers of preclinical studies have been published, the emphasis here is placed on preclinical and clinical studies that are likely to affect clinical investigations and their implications for advancing the treatment of patients with cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Using cell membranes and EVs as carriers in nanomedicine offers significant advantages, including exceptional biological compatibility, biodegradability, and a superior drug-loading performance.”
From Emerging role of exosomes in cancer therapy: progress and challenges (2025) · cites this paper as [189]
In the citing paper
“Additionally, nanopharmaceuticals derived from cell membranes and their byproducts naturally contain targeting ability, making them especially promising for the research and development of drug transport systems in lymphoma treatment.”
From Emerging role of exosomes in cancer therapy: progress and challenges (2025) · cites this paper as [189]
In the citing paper
“Immobilization of an enzyme on the surface of nanoparticles can increase enzyme stability (31), and we therefore developed DNase I-coated nanoparticles.”
From Cancer cells induce metastasis-supporting neutrophil extracellular DNA traps (2016) · cites this paper as [31]
Citations
Cites
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Multidrug resistance in cancer: role of ATP–dependent transporters
Gottesman, M. M., Fojo, T., & Bates, S. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc706 · Cited by 5,536
Effect of pegylation on pharmaceuticals
Harris, J. M., & Chess, R. B. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1033 · Cited by 3,431
Therapeutic Nanoparticles for Drug Delivery in Cancer
Cho, K., Wang, X., Nie, S., Chen, Z. (., & Shin, D. M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1441 · Cited by 2,978
Self-citationMechanisms of Cancer Drug Resistance
Gottesman, M. M. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.103929 · Cited by 2,643
In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags
Qian, X., Peng, X.-H., Ansari, D. O., Yin-Goen, Q., Chen, G. Z., Shin, D. M., Yang, L., Young, A. N., Wang, M. D., & Nie, S. (2008) · Nature Biotechnology · doi:10.1038/nbt1377 · Cited by 2,201
Self-citationGradishar, W. J., Tjulandin, S., Davidson, N. G. P., Shaw, H., Desai, N. P., Bhar, P., Hawkins, M., & O’Shaughnessy, J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.937 · Cited by 2,159
Polymer conjugates as anticancer nanomedicines
Duncan, R. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1958 · Cited by 1,956
Ligand-targeted therapeutics in anticancer therapy
Allen, T. M. (2002) · Nature reviews. Cancer · doi:10.1038/nrc903 · Cited by 1,648
Kirpotin, D. B., Drummond, D. C., Shao, Y., Shalaby, M. R., Hong, K., Nielsen, U. B., Marks, J. D., Benz, C. C., & Park, J. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4199 · Cited by 1,129
Flagged first, then by citations
2 of the 108 references couldn’t be matched to a known paper.
Research works printed but not linked: 3
- Kurtzberg, J., Moore, J. O. Scudiery, D. & Franklin, A. A phase II study of polyethylene glycol (PEG) conjugated L-asparaginase in patients with refractory acute leukaemias. Proc. Am. Assoc. Cancer Res. 29, 213 (1988).
- Socinski, M. & Ramalingham, S. XYOTAX in NSCLC and other solid tumors. Emerging evidence on biological differences between men and women: is gender-specific therapy warranted? Chemotherapy Foundation web site [online], (2005).
- Vasey, P. et al. Phase I clinical and pharmacokinetic study of PKI (HPMA copolymer doxorubicin) first member of a new class of chemotherapeutics agents: drug–polymer conjugates. Clin. Cancer Res. 5, 83–94 (1999).
Cited by
Sorted by citations
Items 601–700 of 1,023
Poly(Ethylene Glycol)–Polylactide Micelles for Cancer Therapy
Wang, J., Li, S., Han, Y., Guan, J., Chung, S., Wang, C., & Li, D. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00202 · Cited by 155
Investigation of Single‐Drug‐Encapsulating Liposomes using the Nano‐Impact Method
Cheng, W., & Compton, R. G. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201408934 · Cited by 155
Application of nanotechnology to cancer radiotherapy
Mi, Y., Shao, Z., Vang, J., Kaidar‐Person, O., & Wang, A. Z. (2016) · Cancer Nanotechnology · doi:10.1186/s12645-016-0024-7 · Cited by 155
Engineering of magnetic nanoparticles as magnetic particle imaging tracers
Lu, C., Han, L., Wang, J., Wan, J., Song, G., & Rao, J. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00260g · Cited by 156
Multifunctional nanoparticles: recent progress in cancer therapeutics
Raju, G. S. R., Benton, L., Pavitra, E., & Yu, J. S. (2015) · Chemical Communications · doi:10.1039/c5cc04643b · Cited by 155
Li, J., Liu, F., Shao, Q., Min, Y., Costa, M., Yeow, E. K. L., & Xing, B. (2014) · Advanced Healthcare Materials · doi:10.1002/adhm.201300613 · Cited by 157
Ishihara, T., Maeda, T., Sakamoto, H., Takasaki, N., Shigyo, M., Ishida, T., Kiwada, H., Mizushima, Y., & Mizushima, T. (2010) · Biomacromolecules · doi:10.1021/bm100754e · Cited by 155
Hollow nanoparticles from zein for potential medical applications
Xu, H., Jiang, Q., Reddy, N., & Yang, Y. (2011) · Journal of Materials Chemistry · doi:10.1039/c1jm11163a · Cited by 154
Cuboplexes: Topologically Active siRNA Delivery
Kim, H., & Leal, C. (2015) · ACS Nano · doi:10.1021/acsnano.5b03902 · Cited by 157
Xu, W., Qian, J., Hou, G., Suo, A., Wang, Y., Wang, J., Sun, T., Yang, M., Wan, X., & Yao, Y. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b08700 · Cited by 154
Comprehensive Review on Graphene Oxide for Use in Drug Delivery System
Daniyal, M., Liu, B., & Wang, W. (2020) · Current Medicinal Chemistry · doi:10.2174/13816128256661902011296290 · Cited by 160
Micro and nanomotors in diagnostics
Chałupniak, A., Morales‐Narváez, E., & Merkoçi, A. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.09.004 · Cited by 152
Cyclodextrin-derived pH-responsive nanoparticles for delivery of paclitaxel
He, H., Chen, S., Zhou, J., Dou, Y., Song, L., Che, L., Zhou, X. W., Chen, X., Jia, Y., Zhang, J., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.03.068 · Cited by 153
Preclinical to clinical development of the novel camptothecin nanopharmaceutical CRLX101
Svenson, S., Wolfgang, M., Hwang, J., Ryan, J. L., & Eliasof, S. D. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.03.007 · Cited by 153
Tumor vasculature targeting and imaging in living mice with reduced graphene oxide
Shi, S., Yang, K., Hong, H., Valdovinos, H. F., Nayak, T. R., Zhang, Y., Theuer, C. P., Barnhart, T. E., Liu, Z., & Cai, W. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.01.047 · Cited by 154
Emerging functional nanomaterials for therapeutics
Xue, X., Wang, F., & Liu, X. (2011) · Journal of Materials Chemistry · doi:10.1039/c1jm11401h · Cited by 153
Dual-Responsive Polymer Micelles for Target-Cell-Specific Anticancer Drug Delivery
Guo, X., Shi, C., Yang, G., Wang, J., Cai, Z., & Zhou, S. (2014) · Chemistry of Materials · doi:10.1021/cm5012718 · Cited by 153
Tong, Y., Wu, Y. F., Zhao, C., Xu, Y. B., Lu, J., Xiang, S., Zong, F., & Wu, X. (2017) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.7b02197 · Cited by 153
Platinum( iv ) prodrugs with long lipid chains for drug delivery and overcoming cisplatin resistance
Chen, Q., Yang, Y., Lin, X., Ma, W., Chen, G., Li, W., Wang, X., & Yu, Z. (2018) · Chemical Communications · doi:10.1039/c8cc02791a · Cited by 153
Sanna, V., Pintus, G., Roggio, A. M., Punzoni, S., Posadino, A. M., Arca, A., Marceddu, S., Bandiera, P., Uzzau, S., & Sechi, M. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm1013715 · Cited by 152
LIPID–POLYMER HYBRID NANOPARTICLES: SYNTHESIS, CHARACTERIZATION AND APPLICATIONS
Zhang, L., & Zhang, L. (2010) · Nano LIFE · doi:10.1142/s179398441000016x · Cited by 152
Behera, A., & Padhi, S. (2020) · Environmental Chemistry Letters · doi:10.1007/s10311-020-01022-9 · Cited by 152
Zhang, J., Song, L., Xu, L., Fan, Y., Wang, T., Tian, W., Ju, J., & Xu, H. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.686726 · Cited by 153
Fumagalli, L., Esteban-Ferrer, D., Cuervo, A., Carrascosa, J. L., & Gomila, G. (2012) · Nature Materials · doi:10.1038/nmat3369 · Cited by 151
Dimeric Drug Polymeric Micelles with Acid‐Active Tumor Targeting and FRET‐Traceable Drug Release
Guo, X., Wang, L., Duval, K. E. A., Fan, J., Zhou, S., & Chen, Z. (2017) · Advanced Materials · doi:10.1002/adma.201705436 · Cited by 150
Self-citationAn Analysis of the Binding Function and Structural Organization of the Protein Corona
Zhang, Y., Wu, J. L. Y., Lazarovits, J., & Chan, W. C. W. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.0c01853 · Cited by 153
Cai, M., Chen, X., Fu, L., Du, W., Yang, X., Mou, X., & Hu, P.-Y. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.630943 · Cited by 150
Zhang, W., Li, Y., Liu, L., Sun, Q., Shuai, X., Zhu, W. J., & Chen, Y. (2010) · Biomacromolecules · doi:10.1021/bm100116g · Cited by 150
Ponnanikajamideen, M., Rajeshkumar, S., Vanaja, M., & Annadurai, G. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2018.05.006 · Cited by 150
Nanomedicines for Cancer Therapy: Current status, Challenges and Future Prospects
Bor, G., Azmi, I. D. M., & Yaghmur, A. (2019) · Therapeutic Delivery · doi:10.4155/tde-2018-0062 · Cited by 153
Subcellular Performance of Nanoparticles in Cancer Therapy
Liu, C., Han, Y., Kankala, R. K., Wang, S., & Chen, A. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s226186 · Cited by 157
A critical review on zinc oxide nanoparticles: Synthesis, properties and biomedical applications
Dey, S., Mohanty, D., Divya, N., Bakshi, V., Mohanty, A., Rath, D., Das, S., Mondal, A., Roy, S., & Sabui, R. (2024) · Intelligent Pharmacy · doi:10.1016/j.ipha.2024.08.004 · Cited by 150
Nanotechnology: emerging tools for biology and medicine
Wong, I. Y., Bhatia, S. N., & Toner, M. (2013) · Genes & Development · doi:10.1101/gad.226837.113 · Cited by 132
Yang, R., Meng, F., Ma, S., Huang, F., Liu, H., & Zhong, Z. (2011) · Biomacromolecules · doi:10.1021/bm2006856 · Cited by 149
Antoine, T. E., Hadigal, S. R., Yakoub, A. M., Mishra, Y. K., Bhattacharya, P., Haddad, C., Vályi-Nagy, T., Adelung, R., Prabhakar, B. S., & Shukla, D. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502373 · Cited by 149
Inorganic Nanocarriers Overcoming Multidrug Resistance for Cancer Theranostics
Lin, G., Mi, P., Chu, C., Zhang, J., & Liu, G. (2016) · Advanced Science · doi:10.1002/advs.201600134 · Cited by 154
Exploring the Tumor Microenvironment with Nanoparticles
Miao, L., & Huang, L. (2015) · Cancer treatment and research · doi:10.1007/978-3-319-16555-4_9 · Cited by 155
Liu, Y., Hou, W., Xia, L., Cui, C., Wan, S., Jiang, Y. Y., Yang, Y. P., Wu, Q., Qiu, L., & Tan, W. (2018) · Chemical Science · doi:10.1039/c8sc02210k · Cited by 149
Zhu, X., Li, J., Peng, P., Hosseini-Nassab, N., & Smith, B. R. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b01202 · Cited by 149
Su, W., Su, W., Cheng, C., Shieh, & Yeh (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s33666 · Cited by 148
Innovative pharmaceutical development based on unique properties of nanoscale delivery formulation
Kumar, A., Chen, F., Mozhi, A., Zhang, X., Zhao, Y., Xue, X., Hao, Y., Zhang, X., Wang, P. C., & Liang, X. (2013) · Nanoscale · doi:10.1039/c3nr01525d · Cited by 152
Acoustic Separation of Nanoparticles in Continuous Flow
Wu, M., Mao, Z., Chen, K., Bachman, H., Chen, Y., Rufo, J., Ren, L., Li, P., Wang, L., & Huang, T. J. (2017) · Advanced Functional Materials · doi:10.1002/adfm.201606039 · Cited by 149
de Oliveira, J. P., Prado, A. R., Keijok, W. J., Antunes, P. W. P., Yapuchura, E. R., & Guimarães, M. C. C. (2019) · Scientific Reports · doi:10.1038/s41598-019-50424-5 · Cited by 148
Lee, K., Lee, H., Bae, K. H., & Park, T. G. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.04.046 · Cited by 147
Lipid- and Polymer-Based Nanostructures for Cancer Theranostics
Luk, B. T., Fang, R. H., & Zhang, L. (2012) · Theranostics · doi:10.7150/thno.4381 · Cited by 147
DNA Nanotechnology for Cancer Therapeutics
Kumar, V., Palazzolo, S., Bayda, S., Corona, G., Toffoli, G., & Rizzolio, F. (2016) · Theranostics · doi:10.7150/thno.14203 · Cited by 147
A Comprehensive Review on Intracellular Delivery
Rad, D. M., Rad, M. A., Bazaz, S. R., Kashaninejad, N., Jin, D., & Warkiani, M. E. (2021) · Advanced Materials · doi:10.1002/adma.202005363 · Cited by 155
Near-infrared light sensitive polypeptide block copolymer micelles for drug delivery
Kumar, S., Allard, J.-F., Morris, D., Dory, Y. L., Lepage, M., & Zhao, Y. (2012) · Journal of Materials Chemistry · doi:10.1039/c2jm16380b · Cited by 146
Targeted Iron-Oxide Nanoparticle for Photodynamic Therapy and Imaging of Head and Neck Cancer
Wang, D., Fei, B., Halig, L. V., Qin, X., Hu, Z., Xu, H. T., Wang, Y. A., Chen, Z., Kim, S., Shin, D. M., et al. (2014) · ACS Nano · doi:10.1021/nn501652j · Cited by 146
Self-citationWu, X., Wang, Z., Zhu, D., Zong, S., Yang, L., Zhong, Y., & Cui, Y. (2013) · ACS Applied Materials & Interfaces · doi:10.1021/am403092m · Cited by 146
Cancer Cell Invasion: Treatment and Monitoring Opportunities in Nanomedicine
Omid Veiseh, A., Kievit, F. M., Ellenbogen, R. G., & Zhang, M. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.01.010 · Cited by 149
Biological Responses to Engineered Nanomaterials: Needs for the Next Decade
Murphy, C. J., Vartanian, A. M., Geiger, F. M., Hamers, R. J., Pedersen, J. A., Cui, Q., Haynes, C. L., Carlson, E. E., Hernandez, R., Klaper, R. D., et al. (2015) · ACS Central Science · doi:10.1021/acscentsci.5b00182 · Cited by 149
Machtakova, M., Thérien‐Aubin, H., & Landfester, K. (2021) · Chemical Society Reviews · doi:10.1039/d1cs00686j · Cited by 150
Polyvalent Dendrimer-Methotrexate as a Folate Receptor-Targeted Cancer Therapeutic
Thomas, T. P., Huang, B., Choi, S. K., Silpe, J. E., Kotlyar, A., Desai, A. M., Zong, H., Gam, J. J., Joice, M. V., & Baker, J. R. (2012) · Molecular Pharmaceutics · doi:10.1021/mp3002232 · Cited by 145
Tang, S., Yin, Q., Su, J., Sun, H., Meng, Q., Chen, Y., Chen, L., Huang, Y., Gu, W., Xu, M., et al. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.01.049 · Cited by 145
Yang, Y., Pan, D., Luo, K., Li, L., & Gu, Z. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.07.037 · Cited by 145
Nanoparticulate Cellular Patches for Cell-Mediated Tumoritropic Delivery
Cheng, H., Kastrup, C. J., Ramanathan, R., Siegwart, D. J., Ma, M., Bogatyrev, S. R., Xu, Q., Whitehead, K. A., Langer, R., & Anderson, D. G. (2010) · ACS Nano · doi:10.1021/nn901319y · Cited by 145
Translatable High Drug Loading Drug Delivery Systems Based on Biocompatible Polymer Nanocarriers
Chen, W., Zhou, S., Ge, L., Wu, W., & Jiang, X. (2018) · Biomacromolecules · doi:10.1021/acs.biomac.8b00218 · Cited by 144
Karimzadeh, Z., Javanbakht, S., & Namazi, H. (2018) · Bioimpacts · doi:10.15171/bi.2019.02 · Cited by 145
Eliasof, S. D., Lazarus, D. D., Peters, C. G., Case, R. I., Cole, R. O., Hwang, J., Schluep, T., Chao, J., Lin, J. L., Yen, Y., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1309566110 · Cited by 144
Self-citationHDL‐Mimicking Peptide–Lipid Nanoparticles with Improved Tumor Targeting
Zhang, Z., Chen, J., Ding, L., Jin, H., Lovell, J. F., Corbin, I. R., Cao, W., Lo, P., Yang, M., Tsao, M., et al. (2009) · Small · doi:10.1002/smll.200901515 · Cited by 147
Real-time monitoring of drug release
Weinstain, R., Segal, E., Satchi‐Fainaro, R., & Shabat, D. (2009) · Chemical Communications · doi:10.1039/b919329d · Cited by 144
pH-sensitive membrane peptides (pHLIPs) as a novel class of delivery agents
Andreev, O. A., Engelman, D. M., & Reshetnyak, Y. K. (2010) · Molecular Membrane Biology · doi:10.3109/09687688.2010.509285 · Cited by 143
Ligand-based targeted therapy: a novel strategy for hepatocellular carcinoma
Li, M., Zhang, W., Wang, B., Gao, Y., Song, Z., & Zheng, Q. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s115727 · Cited by 148
Mao, K., Fan, Z.-L., Yuan, J., Chen, P.-P., Yang, J., Xu, J., Zhuge, D., Jin, B., Zhu, Q., Shen, B., et al. (2017) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2017.10.029 · Cited by 144
Greener Synthesis of Zinc Oxide Nanoparticles: Characterization and Multifaceted Applications
Aldalbahi, A. K., Alterary, S. S., Almoghim, R. A. A., Awad, M. A., Aldosari, N. S., Alghannam, S. F., Alabdan, A. N., Alharbi, S., Alateeq, B. A. M., Mohsen, A. A. A., et al. (2020) · Molecules · doi:10.3390/molecules25184198 · Cited by 148
Mesoporous‐Silica‐Functionalized Nanoparticles for Drug Delivery
Giret, S., Man, M. W. C., & Carcel, C. (2015) · Chemistry - A European Journal · doi:10.1002/chem.201500578 · Cited by 146
A Folate Receptor-Targeting Nanoparticle Minimizes Drug Resistance in a Human Cancer Model
Wang, X., Li, J., Wang, Y., Koenig, L., Gjyrezi, A., Giannakakou, P., Shin, E. H., Tighiouart, M., Chen, Z. (., Nie, S., et al. (2011) · ACS Nano · doi:10.1021/nn200739q · Cited by 145
Self-citationTimko, B. P., Whitehead, K. A., Gao, W., Kohane, D. S., Farokhzad, O. C., Anderson, D. G., & Langer, R. (2011) · Annual Review of Materials Research · doi:10.1146/annurev-matsci-062910-100359 · Cited by 143
Recent Advances on Inorganic Nanoparticle-Based Cancer Therapeutic Agents
Wang, F., Li, C., Cheng, J., & Yuan, Z. (2016) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph13121182 · Cited by 145
Zhang, C., Pan, D., Luo, K., Li, N., Guo, C., Zheng, X., & Gu, Z. (2014) · Polymer Chemistry · doi:10.1039/c4py00601a · Cited by 142
Ding, M., Song, N., He, X., Li, J., Zhou, L., Tan, H. S., Fu, Q., & Gu, Q. (2013) · ACS Nano · doi:10.1021/nn4002769 · Cited by 142
Switching the Immunogenicity of Peptide Assemblies Using Surface Properties
Wen, Y., Waltman, A., Han, H., & Collier, J. H. (2016) · ACS Nano · doi:10.1021/acsnano.6b03409 · Cited by 142
Murugan, C., Rayappan, K., Thangam, R., Bhanumathi, R., Shanthi, K., Vivek, R., Ramasamy, T., Bhattacharyya, A., Sivasubramanian, S., Gunasekaran, P., et al. (2016) · Scientific Reports · doi:10.1038/srep34053 · Cited by 143
Zhao, T., Wang, P., Li, Q., Al-Khalaf, A. A., Hozzein, W. N., Zhang, F., Li, X., & Zhao, D. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201711354 · Cited by 142
Journal of Global Trends in Pharmaceutical Sciences
Rao, A., Korim, R., Reddy, D. S., & Mujavar, E. (2014) · Cited by 142
Guo, S., Wang, Y., Miao, L., Xu, Z., Lin, C. M., Zhang, Y., & Huang, L. (2013) · ACS Nano · doi:10.1021/nn403606m · Cited by 141
Obaid, G., Chambrier, I., Cook, M. J., & Russell, D. A. (2015) · Photochemical & Photobiological Sciences · doi:10.1039/c4pp00312h · Cited by 141
Cell-penetrating peptides for the delivery of nucleic acids
Lehto, T., Kurrikoff, K., & Langel, Ü. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2012.689285 · Cited by 143
Silk-elastin-like protein biomaterials for the controlled delivery of therapeutics
Huang, W., Rollett, A., & Kaplan, D. L. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2015.989830 · Cited by 141
Gold nanoparticles and angiogenesis: molecular mechanisms and biomedical applications
Darweesh, R. S., Ayoub, N. M., & Nazzal, S. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s223941 · Cited by 149
Rational Design of Polyion Complex Nanoparticles to Overcome Cisplatin Resistance in Cancer Therapy
Yang, X., Du, X., Liu, Y., Zhu, Y., Liu, Y., Li, Y., & Wang, J. (2013) · Advanced Materials · doi:10.1002/adma.201303360 · Cited by 140
Gold nanoparticles in theranostic oncology: current state-of-the-art
Akhter, S., Ahmad, M., Ahmad, F., Storm, G., & Kok, R. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2012.716824 · Cited by 125
Modelling the Transport of Nanoparticles under Blood Flow using an Agent-based Approach
Fullstone, G., Wood, J., Holcombe, M., & Battaglia, G. (2015) · Scientific Reports · doi:10.1038/srep10649 · Cited by 140
Coating nanoparticles with cell membranes for targeted drug delivery
Gao, W., & Zhang, L. (2015) · Journal of drug targeting · doi:10.3109/1061186x.2015.1052074 · Cited by 139
Zhang, J., & Ma, P. X. (2010) · Nano Today · doi:10.1016/j.nantod.2010.06.011 · Cited by 139
Mignani, S. M., Bryszewska, M. J., Klajnert‐Maculewicz, B., Zabłocka, M., & Majoral, J. (2014) · Biomacromolecules · doi:10.1021/bm501285t · Cited by 143
Yafout, M., Ousaid, A., Khayati, Y., & Otmani, I. S. E. (2020) · Scientific African · doi:10.1016/j.sciaf.2020.e00685 · Cited by 144
Fluorescent graphene quantum dots as traceable, pH-sensitive drug delivery systems
Liu, H., Qiu, J., Zhang, R., Li, J., Sang, Y., Tang, W., & Rivera-Gil, P. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s91864 · Cited by 139
Glucan Particles for Macrophage Targeted Delivery of Nanoparticles
Soto, E. R., Caras, A. C., Kut, L. C., Castle, M. K., & Ostroff, G. R. (2011) · Journal of Drug Delivery · doi:10.1155/2012/143524 · Cited by 142
Overcoming Physiological Barriers to Nanoparticle Delivery—Are We There Yet?
Thomas, O. S., & Weber, W. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00415 · Cited by 146
PEGylated nanomedicines: recent progress and remaining concerns
Vllasaliu, D., Fowler, R., & Stolnik, S. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.866651 · Cited by 137
Design of thiol- and light-sensitive degradable hydrogels using Michael-type addition reactions
Kharkar, P. M., Kiick, K. L., & Kloxin, A. M. (2015) · Polymer Chemistry · doi:10.1039/c5py00750j · Cited by 137
Lipoproteins and lipoprotein mimetics for imaging and drug delivery
Thaxton, C. S., Rink, J. S., Naha, P. C., & Cormode, D. P. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.020 · Cited by 142
Molecular engineering solutions for therapeutic peptide delivery
Acar, H., Ting, J., Srivastava, S., LaBelle, J. L., & Tirrell, M. (2017) · Chemical Society Reviews · doi:10.1039/c7cs00536a · Cited by 139
Meng, L., Zhang, W., Li, D., Li, Y., Hu, X., Wang, L., & Li, G. (2015) · Chemical Communications · doi:10.1039/c5cc05785j · Cited by 137
Polymeric nanomedicines for image-guided drug delivery and tumor-targeted combination therapy
Lammers, T., Šubr, V., Ulbrich, K., Hennink, W. E., Storm, G., & Kiessling, F. M. (2010) · Nano Today · doi:10.1016/j.nantod.2010.05.001 · Cited by 137
Leukocyte-mediated Delivery of Nanotherapeutics in Inflammatory and Tumor Sites
Dong, X., Chu, D., & Wang, Z. (2017) · Theranostics · doi:10.7150/thno.18069 · Cited by 137
Zhang, L., Li, R., Chen, H., Wei, J., Qian, H., Su, S., Shao, J., Wang, L., Qian, X., & Liu, B. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s126016 · Cited by 137
Kenari, A. N., Cheng, L., & Hill, A. F. (2020) · Methods · doi:10.1016/j.ymeth.2020.01.001 · Cited by 138
Metadata
- Authors
- Davis, M. E., Chen, Z., & Shin, D. M.
- Affiliations
- California Institute of Technology (US)
- Emory University (US)
- Corresponding author
- Davis, Mark E.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2008-09
- Volume
- 7
- Issue
- 9
- Pages
- 771-782
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2082511916
- Cited by
- 4,233
- References
- 108
- Citations by year
- 2026: 68 · 2025: 134 · 2024: 165 · 2023: 143 · 2022: 171 · 2021: 217 · 2020: 224 · 2019: 260 · 2018: 316 · 2017: 340 · 2016: 364 · 2015: 383 · 2014: 385 · 2013: 332 · 2012: 268
- FWCI
- 7.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- CaltechAUTHORS (California Institute of Technology) (submittedVersion)
- Funders
- National Cancer Institute (U54CA119338)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Physical Sciences › Physics and Astronomy › Radiation › Radiation Therapy and Dosimetry
- Keywords
- nanotherapeutics, cancer therapy, nanomedicine, targeted drug delivery, tumor localization, cellular uptake, clinical translation, clinical trials, anticancer agents, adverse drug reactions
- MeSH terms
- Animals, Antineoplastic Agents, Clinical Trials as Topic, Drug Evaluation, Preclinical, Humans, Neoplasms, Drug Delivery Systems, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review